Imaging modality | Sensitivity (%) | Positive predictive value (%) |
Sestamibi | ||
Dual-phase planar | 41-96 | |
SPECT or SPECT/CT | 67-86 | 91-96 |
Ultrasound | 76-80 | 93 |
4D-CT | 62-88 | 84-90 |
MRI | ||
1.5T | 64-79 | |
3T | 64-98 | 67-95 |
PET-CT | ||
18F-fluorocholine | 92-95 | 92-97 |
11C-methionine | 77 | 98 |